NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Apr 2, 2020
CORRESP Mar 31, 2020
UPLOAD Mar 26, 2020
S-3 Mar 24, 2020 FORM S-3
8-K Mar 20, 2020 FORM 8-K
DEF 14A Feb 19, 2020 DEF 14A
10-Q Feb 14, 2020 FORM 10-Q
8-K Feb 11, 2020 FORM 8-K
PRE 14A Feb 5, 2020 PRE 14A
8-K Jan 28, 2020 FORM 8-K
8-K Jan 27, 2020 FORM 8-K
SC 13G Jan 27, 2020 NANOVIRICIDES, INC.
SC 13G/A Jan 24, 2020 SABBY 13G NNVC 1.24.20
424B1 Jan 24, 2020 424B1
EFFECT Jan 9, 2020
CORRESP Jan 9, 2020
CORRESP Jan 8, 2020
S-1/A Jan 8, 2020 FORM S-1/A
S-1/A Jan 7, 2020 FORM S-1/A
8-K/A Jan 2, 2020 FORM 8-K/A
S-1/A Dec 23, 2019 S-1/A
8-K Dec 19, 2019 FORM 8-K
FWP Dec 17, 2019 FREE WRITING PROSPECTUS
S-1/A Dec 17, 2019 FORM S-1/A
8-K Dec 13, 2019 FORM 8-K
← Newer Page 6 of 23 · 556 filings Older →